A core element of the Catasys solution is to address the physiological dysregulation that often occurs in the brains of substance dependent individuals. Whether an individual suffers from alcohol, cocaine, methamphetamine or opiate dependence, there are now pharmacotherapies available designed to address the underlying physiology of substance dependence and help reduce cravings and anxiety and improve other symptoms of withdrawal such as dysregulated mood and sleep deprivation. People have described this as essentially resetting the brain to a pre-addictive state.
Specially trained and licensed OnTrak providers administer the medical component of the OnTrak program. While treatment modalities such as Naltrexone®, Vivitrol®, Campral®, and Topiramate® are sometimes used when clinically appropriate, the medical component of the OnTrak Medical Treatment Program is primarily administered for members suffering from alcohol, cocaine and methamphetamine addiction, and Suboxone® is primarily used to treat members with an opiate addiction.
The medical component of the OnTrak Treatment Program was designed to address changes in brain chemistry and accelerate members’ entry into recovery by helping to relieve cravings and improving cognitive function, so members can fully engage in psychosocial therapy.
> GABA, Flumazenil and Substance Dependence
> Suboxone Treatment Program